Intraductal papillary mucinous neoplasms (IPMNs) are nonobligatory precursor lesions of pancreatic ductal adenocarcinoma (PDAC). The identification of molecular biomarkers able to predict the risk of progression of IPMNs toward malignancy is largely lacking and sorely needed. Telomere length (TL) is associated with the susceptibility of developing cancers, including PDAC. Moreover, several PDAC risk factors have been shown to be associated with IPMN transition to malignancy. TL is genetically determined, and the aim of this study was to use 11 SNPs, alone or combined in a score (teloscore), to estimate the causal relation between genetically determined TL and IPMNs progression. For this purpose, 173 IPMN patients under surveillance were investigated. The teloscore did not show any correlation, however, we observed an association between PXK-rs6772228-A and an increased risk of IPMN transition to malignancy (HR = 3.17; 95%CI 1.47–6.84; P = 3.24 × 10^-3). This effect was also observed in a validation cohort of 142 IPMNs even though the association was not statistically significant. The combined analysis was consistent showing an association between PXK-rs6772228-A and increased risk of progression. The A allele of this SNP is strongly associated with shorter LTL that in turn have been reported to be associated with increased risk of developing PDAC. These results clearly highlight the importance of looking for genetic variants as potential biomarkers in this setting in order to further our understanding the etiopathogenesis of PDAC and suggest that genetically determined TL might be an additional marker of IPMN prognosis.

The evaluation of the patient’s experience is becoming increasingly important as a better patient experience can improve the quality of the health service delivered. Patient-reported experience measures (PREMs) are self-report assessment tools provided to patients about their experience during any health event. There are few PREM instruments in the field of gastrointestinal endoscopy, and none is specific for endoscopic ultrasound (EUS). This study aims to develop a questionnaire to evaluate the experience of patients undergoing EUS, identifying and prioritizing the factors related to the patient’s experience. The study will consist of several phases: (A) tool creation; (B) face and content validity; (C) ranking: to evaluate the relevance of the identified questions in the previous phase; (D) questionnaire creation and validity testing. The final output will be the production of a specific tool that can be used to measure patients’ experience during EUS. This questionnaire may become a relevant part of actions taken to measure the quality of care provided to patients undergoing EUS. Furthermore, correlation between health care providers’ and patients’ views of the relevance of the included items will allow optimization of empathetic and psychological aspects.

Background/Objectives: The objective of this study was to develop and validate the Clinical Research Nursing Competencies–Self-Efficacy (Se-CRN) scale, a theory-grounded instrument to assess perceived capability in clinical research nursing practice. Methods: A two-phase validation study was conducted using an exploratory sequential mixed-method design between July 2022 and September 2025. The initial item pool was derived from an established competency taxonomy and refined through expert review for face and content validity. The final version of the Se-CRN was administered online to Clinical Research Nurses working with patients enrolled in clinical trials in Italy. Structural validity was examined using exploratory factor analysis with parallel analysis, and reliability was assessed through internal consistency and hierarchical indices. Group differences in self-efficacy were examined across clinical settings, educational levels, and research experience. Results: A total of 183 nurses participated. The data supported a five-factor solution reflecting core dimensions of clinical research nursing (Clinical Practice, Study Management, Human Subject Protection, Contributing to the Science, and Care Coordination and Continuity). Reliability was excellent at the scale level and strong across domains. No differences in perceived capability were observed between oncological and non-oncological settings. Higher self-efficacy was consistently associated with greater experience in the research setting and, to a lesser extent, with advanced education. Conclusions: The Se-CRN is the first validated self-efficacy instrument that captures the full scope of clinical research nursing practice. It provides a practical measure to support training needs assessment, curriculum development, and workforce planning. Further research should confirm the factor structure and examine responsiveness to professional development across diverse settings.